DRUG:
CTM-N2D
i
Other names: CTM-N2D, Haplo/ allogeneic NKG2DL-targetting chimeric antigen receptor-grafted γδ T cell therapy, Haploidentical/ allogeneic natural killer group 2D ligand CAR-γδT cell therapy, NKG2DL-targetting chimeric antigen receptor-grafted gamma delta T cell therapy, Adoptive Cell Transfer of NKG2DL-targetting Chimeric Antigen Receptor-grafted Gamma Delta T cell, CTMN2D, CTM N2D
Contact us to learn more about our Premium Content:
News alerts, weekly reports and conference planners